» Articles » PMID: 33419911

Excess Burden of Age-associated Comorbidities Among People Living with HIV in British Columbia, Canada: a Population-based Cohort Study

Overview
Journal BMJ Open
Specialty General Medicine
Date 2021 Jan 9
PMID 33419911
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: As people living with HIV (PLWH) live longer, morbidity and mortality from non-AIDS comorbidities have emerged as major concerns. Our objective was to compare prevalence trends and age at diagnosis of nine chronic age-associated comorbidities between individuals living with and without HIV.

Design And Setting: This population-based cohort study used longitudinal cohort data from all diagnosed antiretroviral-treated PLWH and 1:4 age-sex-matched HIV-negative individuals in British Columbia, Canada.

Participants: The study included 8031 antiretroviral-treated PLWH and 32 124 HIV-negative controls (median age 40 years, 82% men). Eligible participants were ≥19 years old and followed for ≥1 year during 2000 to 2012.

Primary And Secondary Outcome Measures: The presence of non-AIDS-defining cancers, diabetes, osteoarthritis, hypertension, Alzheimer's and/or non-HIV-related dementia, cardiovascular, kidney, liver and lung diseases were identified from provincial administrative databases. Beta regression assessed annual age-sex-standardised prevalence trends and Kruskal-Wallis tests compared the age at diagnosis of comorbidities stratified by rate of healthcare encounters.

Results: Across study period, the prevalence of all chronic age-associated comorbidities, except hypertension, were higher among PLWH compared with their community-based HIV-negative counterparts; as much as 10 times higher for liver diseases (25.3% vs 2.1%, p value<0.0001). On stratification by healthcare encounter rates, PLWH experienced most chronic age-associated significantly earlier than HIV-negative controls, as early as 21 years earlier for Alzheimer's and/or dementia.

Conclusions: PLWH experienced higher prevalence and earlier age at diagnosis of non-AIDS comorbidities than their HIV-negative controls. These results stress the need for optimised screening for comorbidities at earlier ages among PLWH, and a comprehensive HIV care model that integrates prevention and treatment of chronic age-associated conditions. Additionally, the robust methodology developed in this study, which addresses concerns on the use of administrative health data to measure prevalence and incidence, is reproducible to other settings.

Citing Articles

Healthcare utilisation in people living with HIV: the role of substance use, mood/anxiety disorders and unsustained viral suppression - a retrospective cohort study in British Columbia, Canada, 2001-2019.

Shayegi-Nik S, Wang L, Magee C, Li J, Budu M, Kooij K BMJ Open. 2025; 15(3):e088818.

PMID: 40044190 PMC: 11883530. DOI: 10.1136/bmjopen-2024-088818.


Incidence and contributing factors of dementia among people living with HIV in British Columbia, Canada, from 2002 to 2016: a retrospective cohort study.

Shayegi-Nik S, Honer W, Vila-Rodriguez F, Nanditha N, Patterson T, Guillemi S BMJ Public Health. 2025; 2(1):e000627.

PMID: 40018107 PMC: 11816979. DOI: 10.1136/bmjph-2023-000627.


Associations between multimorbidity burden and objective and patient-reported sleep outcomes among people with HIV.

Sukumaran L, Sabin C, Kunisaki K, Doyle N, Post F, Vera J AIDS. 2024; 39(4):424-433.

PMID: 39601248 PMC: 11872264. DOI: 10.1097/QAD.0000000000004073.


HIV Protein Nef Induces Cardiomyopathy Through Induction of Bcl2 and p21.

Kondrachuck O, Ciccone P, Ford N, Hong K, Kimura Y, Zi J Int J Mol Sci. 2024; 25(21.

PMID: 39518954 PMC: 11547003. DOI: 10.3390/ijms252111401.


Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain.

Izquierdo R, Suarez-Garcia I, Gomez-Garcia T, Marco-Sanchez C, Puente-Ferreiro J, Moreno C HIV Med. 2024; 26(2):308-318.

PMID: 39455423 PMC: 11786618. DOI: 10.1111/hiv.13726.


References
1.
Cook J, Burke-Miller J, Steigman P, Schwartz R, Hessol N, Milam J . Prevalence, Comorbidity, and Correlates of Psychiatric and Substance Use Disorders and Associations with HIV Risk Behaviors in a Multisite Cohort of Women Living with HIV. AIDS Behav. 2018; 22(10):3141-3154. PMC: 6153984. DOI: 10.1007/s10461-018-2051-3. View

2.
. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010; 50(10):1387-96. PMC: 3157754. DOI: 10.1086/652283. View

3.
Bergersen B, Sandvik L, Dunlop O, Birkeland K, Bruun J . Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis. 2003; 22(12):731-6. DOI: 10.1007/s10096-003-1034-z. View

4.
Justice A . HIV and aging: time for a new paradigm. Curr HIV/AIDS Rep. 2010; 7(2):69-76. DOI: 10.1007/s11904-010-0041-9. View

5.
Christensen S, Wolf E, Altevers J, Diaz-Cuervo H . Comorbidities and costs in HIV patients: A retrospective claims database analysis in Germany. PLoS One. 2019; 14(11):e0224279. PMC: 6834270. DOI: 10.1371/journal.pone.0224279. View